TuHURA Biosciences Depreciation & Amortization Growth & History (HURA)
TuHURA Biosciences's depreciation and amortization was $71,265 for fiscal 2025.
View full TuHURA Biosciences company overviewTuHURA Biosciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $71,265 | −$45,445 | −38.94% |
| 2024 · Dec 31 | 2024-12-31 | $116,710 | −$60,667 | −34.20% |
| 2024 · Jun 30 | 2024-06-30 | $55,000 | −$3.2M | −98.33% |
| 2023 · Dec 31 | 2023-12-31 | $177,377 | −$195,716 | −52.46% |
| 2023 · Jun 30 | 2023-06-30 | $3.3M | $3.2M | +5375.00% |
| 2022 | 2022-12-31 | $373,093 | — | — |
| 2022 | 2022-06-30 | $60,000 | $28,000 | +87.50% |
| 2021 | 2021-06-30 | $32,000 | — | — |
TuHURA Biosciences quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $28,104 | $14,733 | +110.19% |
| Q1 2026 | 2026-03-31 | $23,472 | $9,414 | +66.97% |
| Q4 2025 | 2025-12-31 | $22,544 | — | — |
| Q3 2025 | 2025-09-30 | $21,292 | −$7,849 | −26.93% |
| Q2 2025 | 2025-06-30 | $13,371 | −$22,256 | −62.47% |
| Q1 2025 · Mar 31 | 2025-03-31 | $14,058 | −$20,249 | −59.02% |
| Q1 2025 · Sep 30 | 2024-09-30 | $29,141 | $14,141 | +94.27% |
| Q4 2024 | 2024-06-30 | $35,627 | — | — |
| Q1 2024 · Mar 31 | 2024-03-31 | $34,307 | $19,307 | +128.71% |
| Q4 2023 | 2023-12-31 | $15,000 | $0 | 0.00% |
| Q1 2024 · Sep 30 | 2023-09-30 | $15,000 | $0 | 0.00% |
| Q3 2023 | 2023-03-31 | $15,000 | $0 | 0.00% |
| Q2 2023 | 2022-12-31 | $15,000 | $0 | 0.00% |
| Q1 2023 | 2022-09-30 | $15,000 | $0 | 0.00% |
| Q3 2022 | 2022-03-31 | $15,000 | — | — |
| Q2 2022 | 2021-12-31 | $15,000 | — | — |
| Q1 2022 | 2021-09-30 | $15,000 | — | — |
TuHURA Biosciences depreciation and amortization trends
Between the periods ended 2021-06-30 and 2025-12-31, TuHURA Biosciences's depreciation and amortization increased from $32,000 to $71,265, a change of $39,265. The latest reported quarter, Q2 2026, shows $28,104.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TuHURA Biosciences source filings ↗